SE0400707D0 - Transgenic animal model - Google Patents
Transgenic animal modelInfo
- Publication number
- SE0400707D0 SE0400707D0 SE0400707A SE0400707A SE0400707D0 SE 0400707 D0 SE0400707 D0 SE 0400707D0 SE 0400707 A SE0400707 A SE 0400707A SE 0400707 A SE0400707 A SE 0400707A SE 0400707 D0 SE0400707 D0 SE 0400707D0
- Authority
- SE
- Sweden
- Prior art keywords
- transgenic animal
- alzheimer
- disease
- transgene
- animal model
- Prior art date
Links
- 238000011820 transgenic animal model Methods 0.000 title 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 4
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 abstract 2
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 abstract 2
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 abstract 2
- 108700019146 Transgenes Proteins 0.000 abstract 2
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000035772 mutation Effects 0.000 abstract 2
- 230000009261 transgenic effect Effects 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 230000008506 pathogenesis Effects 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0312—Animal model for Alzheimer's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Environmental Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Animal Husbandry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Eye Examination Apparatus (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0400707A SE0400707D0 (sv) | 2004-03-22 | 2004-03-22 | Transgenic animal model |
| US10/593,639 US7709695B1 (en) | 2004-03-22 | 2005-03-17 | Transgenic mouse expressing arctic mutation E693G |
| ES05722229T ES2367310T3 (es) | 2004-03-22 | 2005-03-17 | Modelo transgénico de la enfermedad de alzheimer. |
| AT05722229T ATE511348T1 (de) | 2004-03-22 | 2005-03-17 | Transgenes modell für morbus alzheimer |
| CA002560551A CA2560551A1 (en) | 2004-03-22 | 2005-03-17 | Transgenic model for alzheimer's disease |
| DK05722229.1T DK1729569T3 (da) | 2004-03-22 | 2005-03-17 | Transgen model for Alzheimers syge |
| PCT/SE2005/000383 WO2005089539A1 (en) | 2004-03-22 | 2005-03-17 | Transgenic model for alzheimer’s disease |
| JP2007504909A JP4914343B2 (ja) | 2004-03-22 | 2005-03-17 | アルツハイマー病のためのトランスジェニックモデル |
| AU2005224992A AU2005224992B2 (en) | 2004-03-22 | 2005-03-17 | Transgenic model for Alzheimer's disease |
| EP05722229A EP1729569B1 (en) | 2004-03-22 | 2005-03-17 | Transgenic model for alzheimer's disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0400707A SE0400707D0 (sv) | 2004-03-22 | 2004-03-22 | Transgenic animal model |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0400707D0 true SE0400707D0 (sv) | 2004-03-22 |
Family
ID=32067463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0400707A SE0400707D0 (sv) | 2004-03-22 | 2004-03-22 | Transgenic animal model |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7709695B1 (sv) |
| EP (1) | EP1729569B1 (sv) |
| JP (1) | JP4914343B2 (sv) |
| AT (1) | ATE511348T1 (sv) |
| AU (1) | AU2005224992B2 (sv) |
| CA (1) | CA2560551A1 (sv) |
| DK (1) | DK1729569T3 (sv) |
| ES (1) | ES2367310T3 (sv) |
| SE (1) | SE0400707D0 (sv) |
| WO (1) | WO2005089539A1 (sv) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2082749A3 (en) | 2000-07-07 | 2010-06-30 | Bioarctic Neuroscience AB | Prevention and treatment of Alzheimer's disease |
| SE0401601D0 (sv) | 2004-06-21 | 2004-06-21 | Bioarctic Neuroscience Ab | Protofibril specific antibodies and uses thereof |
| RU2429244C2 (ru) | 2006-03-23 | 2011-09-20 | Байоарктик Ньюросайенс Аб | Улучшенные селективные в отношении протофибрилл антитела и их применение |
| WO2009128772A1 (en) | 2008-04-14 | 2009-10-22 | Mivac Development Aktiebolag | Stable amyloid beta monomers and oligomers |
| KR101634244B1 (ko) * | 2014-06-19 | 2016-06-29 | 한경대학교 산학협력단 | Talen을 이용하여 grk5 넉아웃 마우스를 제조하는 방법 |
| DK3166970T3 (da) | 2014-07-10 | 2021-05-25 | Bioarctic Ab | FORBEDREDE Aß-PROTOFIBRILBINDENDE ANTISTOFFER |
| EP3224381B1 (en) | 2014-11-25 | 2019-09-04 | The Brigham and Women's Hospital, Inc. | Method of identifying a person having a predisposition to or afflicted with a cardiometabolic disease |
| US10683552B2 (en) | 2014-11-25 | 2020-06-16 | Presidents And Fellows Of Harvard College | Clonal haematopoiesis |
| CA3173742A1 (en) * | 2020-02-28 | 2021-09-02 | Rznomics Inc. | Trans-splicing ribozyme specific to apoe4 rna and use thereof |
| CN113957095A (zh) * | 2021-10-22 | 2022-01-21 | 江苏集萃药康生物科技股份有限公司 | 一种用于构建阿尔兹海默症动物模型的构建方法及其核酸组合物和应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07506720A (ja) | 1992-01-07 | 1995-07-27 | アテナ ニューロサイエンシーズ， インコーポレイテッド | アルツハイマー病のトランスジェニック動物モデル |
| US5604102A (en) | 1992-04-15 | 1997-02-18 | Athena Neurosciences, Inc. | Methods of screening for β-amyloid peptide production inhibitors |
| US5455169A (en) | 1992-06-04 | 1995-10-03 | Alzheimer's Institute Of America, Inc. | Nucleic acids for diagnosing and modeling Alzheimer's disease |
| US5449604A (en) | 1992-10-21 | 1995-09-12 | University Of Washington | Chromosome 14 and familial Alzheimers disease genetic markers and assays |
| AU702293B2 (en) | 1993-10-27 | 1999-02-18 | Athena Neurosciences, Inc. | Transgenic animals harboring APP allele having Swedish mutation |
| US5877399A (en) | 1994-01-27 | 1999-03-02 | Johns Hopkins University | Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
| JPH07238035A (ja) * | 1994-02-28 | 1995-09-12 | Kyowa Hakko Kogyo Co Ltd | βアミロイド蛋白質分解剤 |
| US5777194A (en) | 1995-04-26 | 1998-07-07 | Cephalon, Inc. | Gene-targeted mice with humanized Aβ sequence and Swedish FAD mutation |
| US5986054A (en) | 1995-04-28 | 1999-11-16 | The Hospital For Sick Children, Hsc Research And Development Limited Partnership | Genetic sequences and proteins related to alzheimer's disease |
| US6717031B2 (en) | 1995-06-07 | 2004-04-06 | Kate Dora Games | Method for selecting a transgenic mouse model of alzheimer's disease |
| ES2307300T3 (es) | 1996-07-24 | 2008-11-16 | Novartis Ag | Modelo animal transgenico para la enfermedad de alzheimer. |
| US5898094A (en) | 1996-10-21 | 1999-04-27 | University Of South Florida | Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes |
| US20030131364A1 (en) | 1999-04-27 | 2003-07-10 | Karen Duff | Method for producing transgenic animal models with modulated phenotype and animals produced therefrom |
| EP2082749A3 (en) * | 2000-07-07 | 2010-06-30 | Bioarctic Neuroscience AB | Prevention and treatment of Alzheimer's disease |
| US7196163B2 (en) * | 2001-05-22 | 2007-03-27 | Merk & Co., Inc. | Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity |
| US20040248766A1 (en) | 2001-06-18 | 2004-12-09 | Andrea Leblanc | Selective inhibition of intracellular amyloid-beta neurotoxicity in human neurons |
| AU2003285151A1 (en) * | 2002-11-04 | 2004-06-07 | Bioarctic Neuroscience Ab | Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein |
| US20040255341A1 (en) * | 2003-10-21 | 2004-12-16 | Envivo Pharmaceuticals, Inc. | Transgenic flies expressing Abeta42-Arctic |
-
2004
- 2004-03-22 SE SE0400707A patent/SE0400707D0/sv unknown
-
2005
- 2005-03-17 DK DK05722229.1T patent/DK1729569T3/da active
- 2005-03-17 CA CA002560551A patent/CA2560551A1/en not_active Abandoned
- 2005-03-17 US US10/593,639 patent/US7709695B1/en not_active Expired - Fee Related
- 2005-03-17 EP EP05722229A patent/EP1729569B1/en not_active Not-in-force
- 2005-03-17 AU AU2005224992A patent/AU2005224992B2/en not_active Ceased
- 2005-03-17 WO PCT/SE2005/000383 patent/WO2005089539A1/en active Application Filing
- 2005-03-17 AT AT05722229T patent/ATE511348T1/de active
- 2005-03-17 JP JP2007504909A patent/JP4914343B2/ja not_active Expired - Fee Related
- 2005-03-17 ES ES05722229T patent/ES2367310T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ATE511348T1 (de) | 2011-06-15 |
| JP4914343B2 (ja) | 2012-04-11 |
| CA2560551A1 (en) | 2005-09-29 |
| DK1729569T3 (da) | 2011-09-19 |
| AU2005224992B2 (en) | 2010-05-06 |
| AU2005224992A1 (en) | 2005-09-29 |
| US7709695B1 (en) | 2010-05-04 |
| ES2367310T3 (es) | 2011-11-02 |
| JP2007530035A (ja) | 2007-11-01 |
| WO2005089539A1 (en) | 2005-09-29 |
| EP1729569B1 (en) | 2011-06-01 |
| EP1729569A1 (en) | 2006-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1729569T3 (da) | Transgen model for Alzheimers syge | |
| Bi et al. | Uptake and pathogenic effects of amyloid beta peptide 1–42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists | |
| Wengenack et al. | Quantitative histological analysis of amyloid deposition in Alzheimer’s double transgenic mouse brain | |
| WO2006052691A3 (en) | Pet and magnetic resonance for screening alzheimer's disease therapeutics | |
| AU8448301A (en) | Remedies for heart failure | |
| NO20082134L (no) | Monoklonalt antistoff | |
| DE60314236D1 (de) | Verfahren zur diagnose und therapie von schizophrenie | |
| BRPI0510123A (pt) | modelos transgênicos de doença de alzheimer e seu uso no tratamento de uma variedade de doenças neurodegenerativas | |
| EA200702095A1 (ru) | Антитела, направленные против бета-амилоидного пептида, и способы их использования | |
| WO2004007722A3 (en) | Transgenic animal expressing alzheimer’s tau protein | |
| WO2007149293A3 (en) | Transgenic flies expressing tau and amyloid precursor fragment | |
| DE602004028920D1 (de) | Per | |
| ATE548453T1 (de) | Material und methoden, involviert in die protein- aggregation neurodegenerativer krankheiten | |
| Willuweit et al. | Early-onset and robust amyloid pathology in a new homozygous mouse model of Alzheimer's disease | |
| WO2006091964A8 (en) | Regulators of protein misfolding and aggregation and methods of using the same | |
| ATE522230T1 (de) | Biphenyle als bilderzeugungsmittel bei der alzheimerschen krankheit | |
| IL174726A (en) | Non-human animals with transgenic nucleic acid encoded by a mutant perinylin 1 protein | |
| ATE490979T1 (de) | Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende gene | |
| ATE323408T1 (de) | Transgenes tiermodell für neurodegenerative erkrankungen | |
| WO2003093442A3 (en) | Cell cultures from animal models of alzheimer's disease for screening and testing drug efficacy | |
| DE60121324D1 (de) | Tiermodel für neurodegenerative erkrankungen | |
| Tan et al. | Presenilin-1 mutations associated with familial Alzheimer’s disease do not disrupt protein transport from the endoplasmic reticulum to the Golgi apparatus | |
| EP1063298A3 (en) | Transgenic Animal Model for Alzheimer Disease | |
| Deacon | APP-based transgenic models: The Tg2576 model | |
| WO2004062627A3 (en) | In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders |